↓ Skip to main content

Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions

Overview of attention for article published in Frontiers in oncology, September 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions
Published in
Frontiers in oncology, September 2021
DOI 10.3389/fonc.2021.717180
Pubmed ID
Authors

Shuhua Wei, Chunxiao Li, Mengyuan Li, Yan Xiong, Yuliang Jiang, Haitao Sun, Bin Qiu, Christopher J. Lin, Junjie Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 107 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 12 11%
Student > Bachelor 9 8%
Student > Ph. D. Student 7 7%
Researcher 5 5%
Other 4 4%
Other 14 13%
Unknown 56 52%
Readers by discipline Count As %
Medicine and Dentistry 17 16%
Unspecified 12 11%
Computer Science 5 5%
Engineering 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 7 7%
Unknown 59 55%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 October 2021.
All research outputs
#17,285,374
of 26,163,973 outputs
Outputs from Frontiers in oncology
#6,849
of 22,913 outputs
Outputs of similar age
#251,601
of 440,396 outputs
Outputs of similar age from Frontiers in oncology
#368
of 1,447 outputs
Altmetric has tracked 26,163,973 research outputs across all sources so far. This one is in the 31st percentile – i.e., 31% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,913 research outputs from this source. They receive a mean Attention Score of 3.1. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 440,396 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,447 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.